利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

7 条记录 (耗时 0.015 秒)

    AMINOPYRAZOLE DERIVATIVES
    4.
    发明公开
    AMINOPYRAZOLE DERIVATIVES 失效
    氨基吡

    公开(公告)号：EP0945440A4

    公开(公告)日：2001-06-06

    申请号：EP97949109

    申请日：1997-12-12

    申请人： BANYU PHARMA CO LTD

    发明人： FUKAMI TAKEHIRO ,  FUKURODA TAKAHIRO ,  KANATANI AKIO ,  IHARA MASAKI

    IPC分类号： C07D231/38 ,  C07D231/40 ,  C07D401/04 ,  A61K31/415 ,  A61K31/42 ,  A61K31/44 ,  C07D401/12 ,  C07D413/12

    CPC分类号： C07D231/38 ,  C07D231/40 ,  C07D401/04

    摘要： Compounds represented by general formula (I): wherein Ar1 represents an aryl group or a heteroaromatic group which may be substituted with a group selected among halogen atoms and lower alkyl, lower alkenyl, halogenated lower alkyl, lower alkoxy, lower alkylthio, lower alkylamino, di(lower alkyl)amino, acyl, and aryl groups; Ar2 represents an aryl group or heteroaromatic group which may be substituted with a group selected among halogen atoms and lower alkyl, lower alkenyl, halogenated lower alkyl, lower alkoxy, lower alkylthio, lower alkylamino; di(lower alkyl)amino, and aryl groups; n is 0, 1, or 2; and R?1 and R2¿, which may be the same or different, represent each a hydrogen atom or a lower alkyl group or a salts thereof; a process for preparing the same; and a therapeutic agent for bulimia, obesity, or diabetes, comprising the compound or salt thereof as the active ingredient.

    NOVEL UREA DERIVATIVES
    5.
    发明公开
    NOVEL UREA DERIVATIVES 失效
    新的脲衍生物

    公开(公告)号：EP0955293A4

    公开(公告)日：2000-02-23

    申请号：EP97946071

    申请日：1997-12-02

    申请人： BANYU PHARMA CO LTD

    发明人： FUKAMI TAKEHIRO ,  FUKURODA TAKAHIRO ,  KANATANI AKIO ,  IHARA MASAKI

    IPC分类号： C07D231/40 ,  C07D401/04 ,  C07D401/12 ,  C07D403/12 ,  C07D405/04 ,  A61K31/415

    CPC分类号： C07D401/04 ,  C07D231/40 ,  C07D401/12 ,  C07D403/12 ,  C07D405/04

    摘要： Compounds represented by general formula (I) or salts thereof, a process for producing the same, and a remedy for hyperphagia, adiposis, or diabetes which comprises the same as the active ingredient: wherein A represents nitrogen or a group represented by C-R5; Ar1 represents aryl optionally having substituent(s) selected from the group consisting of halogeno, lower alkyl, and lower haloalkyl; Ar2 represents aryl or heteroaryl optionally having substituent(s) selected from the group consisting of halogeno, lower alkyl, lower alkenyl, lower haloalkyl, lower alkoxy, lower alkylthio, lower alkylamino, lower dialkylamino, and aryl; R1 represents hydrogen or lower alkyl or is bonded to R5 to represent a bond; R2 represents hydrogen or lower alkyl; R?3 and R4¿ are the same or different and each represents hydrogen or lower alkyl, or R?3 and R4¿ are bonded to each other to represent C¿2-4? alkylene optionally having lower alkyl; and R?5¿ represents hydrogen, hydroxy, lower alkyl, or lower alkoxy or is bonded to R1 to represent a bond.

    NOVEL AMINOPYRAZOLE DERIVATIVES
    6.
    发明公开
    NOVEL AMINOPYRAZOLE DERIVATIVES 失效
    氨基吡

    公开(公告)号：EP0945439A4

    公开(公告)日：2000-02-23

    申请号：EP97947904

    申请日：1997-12-12

    申请人： BANYU PHARMA CO LTD

    发明人： FUKAMI TAKEHIRO ,  FUKURODA TAKAHIRO ,  KANATANI AKIO ,  IHARA MASAKI

    IPC分类号： C07D231/40 ,  C07D401/12 ,  A61K31/415 ,  A61K31/445

    CPC分类号： C07D401/12 ,  C07D231/40

    摘要： Compounds represented by general formula (I), (wherein Ar1 represents an aryl group which may be substituted with a group selected among halogen atoms and lower alkyl and halogenated lower alkyl groups; Ar2 represents an aryl group or a heteroaromatic group which may be substituted with a group selected among halogen atoms and lower alkyl, lower alkenyl, halogenated lower alkyl, lower alkoxy, lower alkylthio, lower alkylamino, di(lower alkyl)amino, and aryl groups; R?1 and R2¿, which may be the same or different, represent each a hydrogen atom or a lower alkyl group; R?3 and R4¿, which may be the same or different, represent each a hydrogen atom or a lower alkyl group, or R?3 and R4¿ combine with each other to form an alkylene group bearing 2 to 4 carbon atoms and optionally having a lower alkyl group; and R5 represents a hydrogen atom or a lower alkyl or lower alkoxy group) or salts thereof; a process for preparing the same; and a therapeutic agent for bulimia, obesity, or diabetes, comprising the compound or salt thereof as the active ingredient.

    PYRAZOLE DERIVATIVES
    7.
    发明公开
    PYRAZOLE DERIVATIVES 失效
    吡唑衍生物

    公开(公告)号：EP0945438A4

    公开(公告)日：2000-02-23

    申请号：EP97947901

    申请日：1997-12-12

    申请人： BANYU PHARMA CO LTD

    发明人： FUKAMI TAKEHIRO ,  FUKURODA TAKAHIRO ,  KANATANI AKIO ,  IHARA MASAKI

    IPC分类号： C07D231/40 ,  C07D401/04 ,  C07D401/12 ,  C07D403/04 ,  C07D403/12 ,  C07D405/04 ,  C07D405/12 ,  C07D409/12 ,  C07D487/04 ,  A61K31/415 ,  A61K31/44 ,  A61K31/47

    CPC分类号： C07D401/04 ,  C07D231/40 ,  C07D401/12 ,  C07D403/04 ,  C07D403/12 ,  C07D405/04 ,  C07D405/12 ,  C07D409/12 ,  C07D487/04

    摘要： Compounds represented by general formula (I), (wherein ring A and ring B are in a state of ortho fusion, the ring A representing an aromatic carbocyclic or heterocyclic ring, and the ring B representing a four- to seven-membered aliphatic carbocyclic or nitrogen-containing heterocyclic ring wherein the nitrogen atom can be present in only the site of fusion with the ring A; Ar represents an aromatic carbocyclic or heterocyclic group optionally substituted with a group selected among halogen atoms and lower alkyl, lower alkenyl, halogenated lower alkyl, lower alkoxy, lower alkylthio, lower alkylamino, di(lower alkyl)amino, and aromatic carbocyclic groups; and R represents a substituent selected among halogen atoms, nitro, lower alkyl, lower alkoxy, aromatic carbocyclic groups, and a carbonyl group having an aromatic carbocyclic group, or a hydrogen atom, provided that when the group represented by formula (a), is the group represented by formula (b), Ar represents neither phenyl nor 4-chlorophenyl) or salts thereof; a process for preparing the same; and a therapeutic agent for bulimia, obesity, or diabetes, comprising the compound or salt thereof as the active ingredient.